Synonyms: compound 23 [PMID: 15990302] | GW806742X
Compound class:
Synthetic organic
Comment: This small molecule acts as an inhibitor of the activity of mixed lineage kinase domain like pseudokinase MLKL. The compound binds the nucleotide binding site within the MLKL pseudokinase domain and reduces MLKL translocation to the cell membrane, which has the effect of preventing MLKL-driven necroptosis (necroptosis being a form of regulated inflammatory cell death [2]) [1]. This effect is driven by blocking the conformational change in the N-terminal four-helix bundle (4HB) domain of the protein caused by nucleotide binding that is required for membrane translocation and killing activity. This compound was originally identified as a nanomolar potency inhibitor of VEGFR2 tyrosine kinase [3], but note that inhibition of VEGFR2 by another VEGFR2 inhibitor (sorafenib) does not prevent necroptosis, suggesting a direct role for MLKL in this form of cell death, and also demonstrates that targeting the nucleotide binding site of pseudokinases is a novel strategy for modulating signal transduction. In summary, MLKL compound 1 provides a useful tool for investigating necroptosis.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|